Search Results | Journal of Experimental Medicine

Skip Nav Destination

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Characterization of the interleukin 2 receptors (IL-2R) expressed on human natural killer cells activated in vivo by IL-2: association of the p64 IL-2R gamma chain with the IL-2R beta chain in functional intermediate-affinity IL-2R.

S D Voss, P M Sondel, R J Robb

J Exp Med (1992) 176 (2): 531–541.

DOI: https://doi.org/10.1084/jem.176.2.531

Published: 01 August 1992

View article

Journal Articles

Increased expression of the interleukin 2 (IL-2) receptor beta chain (p70) on CD56+ natural killer cells after in vivo IL-2 therapy: p70 expression does not alone predict the level of intermediate affinity IL-2 binding.

S D Voss, R J Robb, G Weil-Hillman, J A Hank, K Sugamura, M Tsudo, P M Sondel

J Exp Med (1990) 172 (4): 1101–1114.

DOI: https://doi.org/10.1084/jem.172.4.1101

Published: 01 October 1990

View article

Journal Articles

Internalization of interleukin 2 is mediated by the beta chain of the high-affinity interleukin 2 receptor.

R J Robb, W C Greene

J Exp Med (1987) 165 (4): 1201–1206.

DOI: https://doi.org/10.1084/jem.165.4.1201

Published: 01 April 1987

View article

Journal Articles

Stable expression of cDNA encoding the human interleukin 2 receptor in eukaryotic cells.

W C Greene, R J Robb, P B Svetlik, C M Rusk, J M Depper, W J Leonard

J Exp Med (1985) 162 (1): 363–368.

DOI: https://doi.org/10.1084/jem.162.1.363

Published: 01 July 1985

View article

Journal Articles

Expression of interleukin 2 receptors on activated human B cells.

T A Waldmann, C K Goldman, R J Robb, J M Depper, W J Leonard, S O Sharrow, K F Bongiovanni, S J Korsmeyer, W C Greene

J Exp Med (1984) 160 (5): 1450–1466.

DOI: https://doi.org/10.1084/jem.160.5.1450

Published: 01 November 1984

View article

Journal Articles

Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen.

R J Robb, W C Greene, C M Rusk

J Exp Med (1984) 160 (4): 1126–1146.

DOI: https://doi.org/10.1084/jem.160.4.1126

Published: 01 October 1984

View article

Journal Articles

Direct demonstration of the identity of T cell growth factor binding protein and the Tac antigen.

R J Robb, W C Greene

J Exp Med (1983) 158 (4): 1332–1337.

DOI: https://doi.org/10.1084/jem.158.4.1332

Published: 01 October 1983

View article

Journal Articles

Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells.

E A Grimm, R J Robb, J A Roth, L M Neckers, L B Lachman, D J Wilson, S A Rosenberg

J Exp Med (1983) 158 (4): 1356–1361.

DOI: https://doi.org/10.1084/jem.158.4.1356

Published: 01 October 1983

View article

NARROW

Characterization of the interleukin 2 receptors (IL-2R) expressed on human natural killer cells activated in vivo by IL-2: association of the p64 IL-2R gamma chain with the IL-2R beta chain in functional intermediate-affinity IL-2R.

Increased expression of the interleukin 2 (IL-2) receptor beta chain (p70) on CD56+ natural killer cells after in vivo IL-2 therapy: p70 expression does not alone predict the level of intermediate affinity IL-2 binding.

Internalization of interleukin 2 is mediated by the beta chain of the high-affinity interleukin 2 receptor.

Stable expression of cDNA encoding the human interleukin 2 receptor in eukaryotic cells.

Expression of interleukin 2 receptors on activated human B cells.

Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen.

Direct demonstration of the identity of T cell growth factor binding protein and the Tac antigen.

Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells.

Email alerts

Email alerts

This Feature Is Available To Subscribers Only